Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia

NCT03844997 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
AML

Interventions

DRUG: Palcociclib
DRUG: CPX-351

Sponsor

Sudipto Mukherjee, MD, PhD, MPH